SOTACOR

This brand name is authorized in Australia, Brazil, Finland, Japan, New Zealand, United Kingdom

Active ingredients

The drug SOTACOR contains one active pharmaceutical ingredient (API):

1 Sotalol
UNII HEC37C70XX - SOTALOL HYDROCHLORIDE

D,l-sotalol is a non-selective hydrophilic β-adrenergic receptor blocking agent, devoid of intrinsic sympathomimetic activity or membrane stabilizing activity. Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties.

Read about Sotalol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SOTACOR Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07AA07 Sotalol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AA Beta blocking agents, non-selective
Discover more medicines within C07AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2043M, 8398B
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505105501118317, 505105502114315
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 027938
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 184856
Country: JP 医薬品医療機器総合機構 Identifier(s): 2129013F1026, 2129013F2022
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2235, 2236, 2237

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.